NCT03277924 2024-08-13
ImmunoSarc
Grupo Espanol de Investigacion en Sarcomas
Phase 1/2 Completed
Clinical Trials
13 trialsNCT01459484 2024-05-20
ISG/OS-2
Italian Sarcoma Group
Phase 2 Completed
NCT00667342 2023-08-07
A Study of Bevacizumab in Combination With Chemotherapy for Treatment of Osteosarcoma
St. Jude Children's Research Hospital
Phase 2 Completed
NCT00134030 2023-06-07
EURAMOS-1
Children's Oncology Group
Phase 3 Completed
NCT02986503 2016-12-08
EUROBOSS
Italian Sarcoma Group
Completed
NCT00586846 2016-01-20
Phase II Study of Chemotherapy and Pamidronate for the Treatment of Newly Diagnosed Osteosarcoma
Memorial Sloan Kettering Cancer Center
Phase 2 Completed
NCT00742924 2014-07-04
Zoledronic Acid and Combination Chemotherapy in Treating Patients With Newly Diagnosed Metastatic Osteosarcoma
Children's Oncology Group
Phase 1 Completed
NCT00003776 2013-06-21
Combination Chemotherapy and Surgery in Treating Patients With Newly Diagnosed Metastatic Osteosarcoma
Memorial Sloan Kettering Cancer Center
Phase 2 Completed
NCT00002466 2013-06-20
Combination Chemotherapy and Radiation Therapy in Treating Patients With Peripheral Neuroectodermal Tumors, Ewing's Sarcoma, Wilms' Tumor, or Bone Cancer
Memorial Sloan Kettering Cancer Center
Phase 2 Completed
NCT00023998 2013-02-04
Chemotherapy With or Without Trastuzumab in Treating Patients With Metastatic Osteosarcoma
National Cancer Institute (NCI)
Phase 2 Completed
NCT00145639 2011-06-10
Osteosarcoma1999-A Study Of Intensive Chemotherapy for Osteosarcoma
St. Jude Children's Research Hospital
Phase 2 Completed
NCT00001209 2008-03-04
A Pilot Study for the Treatment of Patients With Metastatic and High Risk Sarcomas and Primitive Neuroectodermal Tumors
National Institutes of Health Clinical Center (CC)
Phase 1 Completed
NCT00180908 2005-09-16
Comparison of High-Dose Methotrexate (HDM) Plus Doxorubicin to HDM Plus Etoposide-Ifosfamide in Osteosarcoma Children
Gustave Roussy, Cancer Campus, Grand Paris
Phase 3 Completed